Business
Director/PDMR and PCA Share Dealings
Director/PDMR and PCA Share Dealings.
About this update from Creo Medical Group Plc
[{"type":"text","content":"\n \n \n LEI: 213800H188ZDCWWXFA21\n \n \n \n \n \n \n \n \n 13 March 2023\n \n \n \n \n \n \n Creo Medical Group plc\n \n \n \n (\"Creo\" or the \"Company\")\n \n \n \n \n \n \n Director/PDMR and PCA Share Dealings\n \n \n \n \n \n \n \n \n Further to the announcements made on 16 February 2023 and 8 March 2023, and pursuant to the recent fundraising, the Company confirms that each of the Company's Directors, Luis Collantes, a member of the Company's senior leadership team and a director of various of the Company's subsidiaries and certain PCAs, have either themselves or through parties affiliated with them acquired New Ordinary Shares at the Issue Price of 20 pence per Ordinary Share as follows:\n \n \n \n \n \n \n \n \n \n \n \n \n \n Director/PDMR Name\n \n \n \n \n \n \n No. of New Ordinary Shares Acquired\n \n \n \n \n \n \n Resultant Shareholding post transaction\n \n \n \n \n \n \n % of voting rights post transaction\n \n \n \n \n \n \n \n Charles Spicer\n \n \n \n \n 165,119\n \n \n \n \n 308,530\n \n \n \n \n 0.09%\n \n \n \n \n \n \n Craig Gulliford*\n \n \n \n \n 1,000,000\n \n \n \n \n 1,630,466\n \n \n \n \n 0.46%\n \n \n \n \n \n \n Richard Rees\n \n \n \n \n 2,715,322\n \n \n \n \n 2,805,902\n \n \n \n \n 0.79%\n \n \n \n \n \n \n Professor Christopher Hancock\n \n \n \n \n 383,171\n \n \n \n \n 4,802,352\n \n \n \n \n 1.36%\n \n \n \n \n \n \n David Woods\n \n \n \n \n 415,255\n \n \n \n \n 440,255\n \n \n \n \n 0.13%\n \n \n \n \n \n \n John Bradshaw\n \n \n \n \n 1,265,135\n \n \n \n \n 1,371,082\n \n \n \n \n 0.39%\n \n \n \n \n \n \n Ivonne Cantu\n \n \n \n \n 125,000\n \n \n \n \n 125,000\n \n \n \n \n 0.04%\n \n \n \n \n \n \n Luis Collantes**\n \n \n \n \n 4,442,485\n \n \n \n \n 4,442,485\n \n \n \n \n 1.27%\n \n \n \n \n \n \n \n \n \n * These 1,000,000 shares are held by the spouse of Craig Gulliford\n \n \n **Shares held via Monkey Business Consultants SL, a company owned and managed by Luis Collantes.\n \n \n \n \n \n \n \n \n \n \n \n \n \n Creo Medical Group plc\n \n \n \n \n \n \n \n www.creomedical.com\n \n \n \n \n \n \n \n \n Richard Rees (CFO)\n \n \n \n \n +44 (0)1291 606 005\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Cenkos Securities plc (Nominated Adviser, Joint Bookrunner and Joint Broker)\n \n \n \n \n...